2
Press release: STADA expands production network with EUR50m project in Romania
One documentmore
Stories from Bad Vilbel
-
-
Press release: STADA sets up for success with Erin Federman as global biosimilars commercial head
One documentmore Press release: Bioglan and STADA partner to increase capacity to meet rising demand for Parkinson’s treatment
One documentmorePress release: Bioglan and STADA partner to increase capacity to meet rising demand for Parkinson’s treatment
One documentmorePress release: NTC and STADA partner for a portfolio of ophthalmic products in the MENA region
One documentmorePress release: STADA continues to outpace the market in H1 and strengthens basis for further growth
One documentmorePress Release: STADA and Sanofi strike consumer healthcare distribution agreement in selected countries in Europe
One documentmorePress release: STADA and partner Xbrane advance biosimilar ranibizumab candidate
One documentmoreSTADA further grows European Consumer Healthcare portfolio by acquiring 16 well-established brands from Sanofi
One documentmoreSTADA Health Report 2021: A year that changed Europe’s health landscape
2 Documentsmore-
Press release: STADA focuses even more on a future-oriented growth culture – Head of Global Human Resources Simone Berger moves up to STADA's Executive Board
One documentmore STADA shows resilience with double-digit growth in 2020
One documentmore-
STADA attracts Bryan Kim as Global Head of Specialties
One documentmore STADA starts European roll-out of Lecigon® Parkinson’s therapy with launches in Germany and Austria
One documentmoreSTADA starts European roll-out of Lecigon® Parkinson’s therapy with launches in Germany and Austria
One documentmoreSTADA signs agreement to commercialize Rupafin® (rupatadine) in the MENA region
One documentmoreSTADA extends ViruProtect partnership with Enzymatica to cover Nordic region
One documentmoreSTADA extends ViruProtect partnership with Enzymatica to cover Nordic region
One documentmore- 2
Nico Reinhold new Global Head of Digital Communications at STADA
One documentmore STADA and PharmaMar sign agreement to commercialize Yondelis® (trabectedin) in the MENA region
One documentmoreEnyzmatica and STADA extend agreement on ViruProtect to Russia, Poland, Ukraine and CIS countries
One documentmoreEuropean Pharmaceutical Company STADA Enters Exclusive Medical Cannabis Partnership with MediPharm Labs
One documentmoreSTADA expands specialty footprint through acquisition of innovative therapy for treating advanced Parkinson's disease
One documentmoreSTADA's US partner Supernus submits NDA for apomorphine infusion pump
One documentmore-
Press release - Romaniszyn leads STADA Poland's growth strategy
One documentmore STADA continues to grow strongly during challenging times
One documentmorePress Release: Nidda Healthcare GmbH sets cash compensation for the transfer of the shares of the minority shareholders of STADA Arzneimittel AG at 98.51 EUR
One documentmoreKOPIE VON: Nidda Healthcare GmbH intends to conduct a squeeze-out of minority shareholders in STADA Arzneimittel AG under stock corporation law
One documentmoreNidda Healthcare GmbH intends to conduct a squeeze-out of minority shareholders in STADA Arzneimittel AG under stock corporation law
One documentmore-
Press release: Alvotech and STADA agree on strategic biosimilar partnership
One documentmore
12Next